Lettieri JT - Search Results

1

Effect of ciprofloxacin on the pharmacokinetics and pharmacodynamics of warfarin.

Israel DS, Stotka J, Rock W, Sintek CD, Kamada AK, Klein C, Swaim WR, Pluhar RE, Toscano JP, Lettieri JT, Heller AH, Polk RE. Israel DS, et al. Among authors: lettieri jt. Clin Infect Dis. 1996 Feb;22(2):251-6. doi: 10.1093/clinids/22.2.251. Clin Infect Dis. 1996. PMID: 8838180 Clinical Trial.

2

Pharmacokinetics of high-dose intravenous ciprofloxacin in young and elderly and in male and female subjects.

Shah A, Lettieri J, Nix D, Wilton J, Heller AH. Shah A, et al. Antimicrob Agents Chemother. 1995 Apr;39(4):1003-6. doi: 10.1128/AAC.39.4.1003. Antimicrob Agents Chemother. 1995. PMID: 7785969 Free PMC article.

3

Comparative pharmacokinetics and safety of ciprofloxacin 400 mg i.v. thrice daily versus 750 mg po twice daily.

Shah A, Lettieri J, Kaiser L, Echols R, Heller AH. Shah A, et al. J Antimicrob Chemother. 1994 Apr;33(4):795-801. doi: 10.1093/jac/33.4.795. J Antimicrob Chemother. 1994. PMID: 8056698 Clinical Trial.

4

Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral doses.

Lettieri JT, Rogge MC, Kaiser L, Echols RM, Heller AH. Lettieri JT, et al. Antimicrob Agents Chemother. 1992 May;36(5):993-6. doi: 10.1128/AAC.36.5.993. Antimicrob Agents Chemother. 1992. PMID: 1510426 Free PMC article. Clinical Trial.

5

Pharmacokinetics of intravenous ciprofloxacin in normal and renally impaired subjects.

Shah A, Lettieri J, Blum R, Millikin S, Sica D, Heller AH. Shah A, et al. J Antimicrob Chemother. 1996 Jul;38(1):103-16. doi: 10.1093/jac/38.1.103. J Antimicrob Chemother. 1996. PMID: 8858462 Clinical Trial.

6

The influence of age and gender on the pharmacokinetics of moxifloxacin.

Sullivan JT, Lettieri JT, Liu P, Heller AH. Sullivan JT, et al. Among authors: lettieri jt. Clin Pharmacokinet. 2001;40 Suppl 1:11-8. doi: 10.2165/00003088-200140001-00002. Clin Pharmacokinet. 2001. PMID: 11352437 Clinical Trial.

7

Influence of age on the safety, tolerability, and pharmacokinetics of the novel HMG-CoA reductase inhibitor cerivastatin in healthy male volunteers.

Mazzu A, Lettieri J, Kaiser L, Mullican W, Heller AH. Mazzu A, et al. J Clin Pharmacol. 1998 Aug;38(8):715-9. doi: 10.1002/j.1552-4604.1998.tb04811.x. J Clin Pharmacol. 1998. PMID: 9725547 Clinical Trial.

8

Pharmacokinetics of a once-daily oral dose of moxifloxacin (Bay 12-8039), a new enantiomerically pure 8-methoxy quinolone.

Sullivan JT, Woodruff M, Lettieri J, Agarwal V, Krol GJ, Leese PT, Watson S, Heller AH. Sullivan JT, et al. Among authors: lettieri j. Antimicrob Agents Chemother. 1999 Nov;43(11):2793-7. doi: 10.1128/AAC.43.11.2793. Antimicrob Agents Chemother. 1999. PMID: 10543767 Free PMC article. Clinical Trial.

9

Influence of gender on the pharmacokinetics, safety, and tolerability of cerivastatin in healthy adults.

Isaacsohn J, Zinny M, Mazzu A, Lettieri J, Heller AH. Isaacsohn J, et al. Eur J Clin Pharmacol. 2001 Mar;56(12):897-903. doi: 10.1007/s002280000225. Eur J Clin Pharmacol. 2001. PMID: 11317478 Clinical Trial.

10

Safety and tolerance of intravenous nimodipine.

Sramek JJ, Heller AH, Sundaresan PR, Lettieri J, Sawin S, Cutler NR. Sramek JJ, et al. Ann Pharmacother. 1994 Oct;28(10):1143-8. doi: 10.1177/106002809402801001. Ann Pharmacother. 1994. PMID: 7841566 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters